Patents-Review.com
ClassID:

109913 ⎘

C12N2710/16734 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae; Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260115280
2026-04-30

VACCINES

 #2
20260115278
2026-04-30

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

 #3
20260069681
2026-03-12

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

 #4
20260027199
2026-01-29

METHODS OF VACCINATING PIGS AGAINST PSEUDORABIES VIRUS

 #5
20250368688
2025-12-04

VARICELLA-ZOSTER VIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES

 #6
20250325655
2025-10-23

VACCINE ADJUVANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #7
20250236646
2025-07-24

TRUNCATED VARICELLA-ZOSTER VIRUS ENVELOPE GLYCOPROTEIN GE

 #8
20250206785
2025-06-26

ANTIGEN DELIVERY PLATFORMS

 #9
20250188132
2025-06-12

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

 #10
20250163105
2025-05-22

IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINE

 #11
20250161425
2025-05-22

SIGNAL SEQUENCES FOR NUCLEIC ACID VACCINES

 #12
20250041407
2025-02-06

VARICELLA ZOSTER VIRUS (VZV) VACCINE

 #13
20240398937
2024-12-05

PSEUDORABIES VIRUS (PRV) EXPRESSING PORCINE CIRCOVIRUS 2 (PCV2) CAPSID PROTEIN ON ENVELOPE AND USE THEREOF

 #14
20240390484
2024-11-28

RNA FORMULATIONS AND LIPIDS

 #15
20240390473
2024-11-28

CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES

 #16
20240374715
2024-11-14

TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

 #17
20240366754
2024-11-07

PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF VIRAL ANTIGENS AND RELATED METHODS

 #18
20240335529
2024-10-10

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

 #19
20240270796
2024-08-15

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

 #20
20240226284
2024-07-11

NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS

 #21
20240084325
2024-03-14

BOVINE HERPESVIRUS TYPE 1 (BoHV-1) QUADRUPLE GENE DELETED MUTANT

 #22
20230272000
2023-08-31

Saponin purification

 #23
20230060631
2023-03-02

DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF

 #24
20220409720
2022-12-29

Varicella zoster virus (VZV) vaccine

 #25
20220363721
2022-11-17

Recombinant varicella-zoster virus (VZV) vaccine

 #26
20220347295
2022-11-03

Vaccine delivery method

 #27
20220226460
2022-07-21

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

 #28
20220193227
2022-06-23

Recombinant virus with diminished latency and methods of using same

 #29
20220119455
2022-04-21

Antigen delivery platforms

 #30
20220062407
2022-03-03

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

 #31
20210187099
2021-06-24

Antigen variant of Varicella Zoster virus and use thereof

 #32
20210163542
2021-06-03

VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE

 #33
20210100890
2021-04-08

EHV insertion site UL43

 #34
20210015916
2021-01-21

Vaccine delivery method

 #35
20200390875
2020-12-17

Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant

 #36
20200317719
2020-10-08

Saponin purification

 #37
20200277577
2020-09-03

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

 #38
20200263147
2020-08-20

Non-neuroinvasive viruses and uses thereof

 #39
20200263146
2020-08-20

Non-neuroinvasive viruses and uses thereof

 #40
20200113996
2020-04-16

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

 #41
20200069793
2020-03-05

Varicella zoster virus (VZV) vaccine

 #42
20190367561
2019-12-05

Vaccine compositions of herpesvirus envelope protein combinations to induce immune response

 #43
20190365884
2019-12-05

Varicella zoster virus vaccine

 #44
20190284577
2019-09-19

EHV with inactivated UL18 and/or UL8

 #45
20190167784
2019-06-06

Recombinant virus with diminished latency and methods of using same

 #46
20190144507
2019-05-16

Antigen delivery platforms

 #47
20190091329
2019-03-28

Cationic oil-in-water emulsions

 #48
20180360939
2018-12-20

Dried saponin liposomal composition

 #49
20180353596
2018-12-13

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

 #50
20180312842
2018-11-01

Immunostimulatory plasmids

 #51
20180256705
2018-09-13

Subunit vaccine of porcine pseudorabies virus and preparation method

 #52
20180208905
2018-07-26

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

 #53
20180185472
2018-07-05

Method of painting micro vesicles

 #54
20180080047
2018-03-22

Promoters

 #55
20180080043
2018-03-22

EHV insertion site ORF70

 #56
20180044643
2018-02-15

Non-neuroinvasive viruses and uses thereof

 #57
20180021424
2018-01-25

Liposomal adjuvant compositions

 #58
20180008700
2018-01-11

VACCINATION

 #59
20170342442
2017-11-30

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

 #60
20170202960
2017-07-20

Cationic oil-in-water emulsions

 #61
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #62
20170165356
2017-06-15

Hybrid core feline vaccines

 #63
20170151319
2017-06-01

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

 #64
20170065715
2017-03-09

Vaccine compositions comprising a saponin adjuvant

 #65
20170049877
2017-02-23

West Nile Virus vaccine

 #66
20160339096
2016-11-24

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

 #67
20160317651
2016-11-03

Method of attenuating porcine pseudorabies virus, attenuated strains of porcine pseudorabies virus, vaccine composition and use thereof

 #68
20160317650
2016-11-03

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

 #69
20160287690
2016-10-06

Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica

 #70
20160281065
2016-09-29

Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof

 #71
20160279231
2016-09-29

Method of attenuating porcine pseudorabies virus, attenuated strains of porcine pseudorabies virus, vaccine composition and use thereof

 #72
20160263211
2016-09-15

Stimulation of neonatal immunity against EHV-1

 #73
20160228540
2016-08-11

Nasal mucosal vaccine composition

 #74
20160228538
2016-08-11

Porcine pseudorabies virus (PRV)-YF strain and its application

 #75
20160206730
2016-07-21

Post release modification of viral envelopes

 #76
20160193327
2016-07-07

Mucosal vaccine composition

 #77
20160193324
2016-07-07

Methods of immunization with varicella zoster virus antigen

 #78
20160130308
2016-05-12

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

 #79
20160114029
2016-04-28

Porcine pseudorabies virus, vaccine composition and preparation method and use thereof

 #80
20160030556
2016-02-04

Bovine virus vaccines that are liquid stable

 #81
20160008458
2016-01-14

Conditionally replication deficient herpes virus and use thereof in vaccines

 #82
20150297704
2015-10-22

Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida

 #83
20150273035
2015-10-01

VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA

 #84
20150267201
2015-09-24

Immunostimulatory plasmids

 #85
20150190502
2015-07-09

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

 #86
20150157704
2015-06-11

Newcastle disease virus vectored herpesvirus vaccines

 #87
20140339126
2014-11-20

Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

 #88
20140328877
2014-11-06

West Nile Virus vaccine

 #89
20140271710
2014-09-18

Liquid stable bovine virus vaccines

 #90
20140271709
2014-09-18

Bovine virus vaccines that are liquid stable

 #91
20140220083
2014-08-07

Cationic oil-in-water emulsions

 #92
20140147466
2014-05-29

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

 #93
20140127259
2014-05-08

Compositions and methods for vaccinating cattle

 #94
20140093535
2014-04-03

Combined vaccines for prevention of porcine virus infections

 #95
20140023673
2014-01-23

Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

 #96
20130295124
2013-11-07

ORF7 deficient varicella virus, vaccine comprising the virus and use thereof

 #97
20130273101
2013-10-17

Vaccine for inducing an improved immune reaction

 #98
20130251747
2013-09-26

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

 #99
20130224244
2013-08-29

Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)

 #100
20130209506
2013-08-15

Recombinant virus with diminished latency and methods of using same

 #101
20130084306
2013-04-04

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

 #102
20130034585
2013-02-07

Bovine herpes virus vaccine with multiple mutations

 #103
20120195927
2012-08-02

gM-negative EHV-mutants without heterologous elements

 #104
20120156238
2012-06-21

HERPES VIRUS BACKBONE FOR VIRAL VACCINE AND VACCINE BASED THEREON

 #105
20120148620
2012-06-14

COMPOSITIONS AND METHODS FOR VACCINATING CATTLE

 #106
20120070453
2012-03-22

Methods for preparing and delivering adjuvant compositions

 #107
20120052089
2012-03-01

Newcastle disease virus vectored herpesvirus vaccines

 #108
20120034267
2012-02-09

INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF

 #109
20110289606
2011-11-24

Equine disease model for herpesvirus neurologic disease and uses thereof

 #110
20110206758
2011-08-25

Vaccine compositions comprising a saponin adjuvant

 #111
20110189233
2011-08-04

Recombinant Varicella-Zoster Virus

 #112
20110182865
2011-07-28

Method for Prophylaxis and Treatment of Equine Herpesvirus Type 1 Infections

 #113
20110159033
2011-06-30

West Nile Virus vaccine

 #114
20110104260
2011-05-05

Vaccine against varicella zoster virus

 #115
20110070164
2011-03-24

Post release modification of viral envelopes

 #116
20110052619
2011-03-03

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

 #117
20110045059
2011-02-24

VACCINE AGAINST VARICELLA ZOSTER VIRUS

 #118
20100291142
2010-11-18

Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof

 #119
20100291115
2010-11-18

PHARMACEUTICAL COMPOSITION FOR THE SUBLINGUAL ADMINISTRATION OF VACCINES, METHOD FOR THE PREPARATION OF THE SAME AND USES THEREOF

 #120
20100279351
2010-11-04

Methods for generation of antibodies

 #121
20100196375
2010-08-05

Engineered scFv against bovine herpes virus type I

 #122
20100178301
2010-07-15

Method of treating pregnant cows and/or heifers

 #123
20100119550
2010-05-13

RECOMBINANT MULTIVALENT VACCINE

 #124
20100092435
2010-04-15

USE OF A VARICELLOVIRUS TAP-INHIBITOR FOR THE INDUCTION OF TUMOR-OR VIRUS-SPECIFIC IMMUNITY AGAINST TEIPP

 #125
20100041023
2010-02-18

Inactivated FCV vaccines

 #126
20100028383
2010-02-04

Chemically defined vaccine stabiliser

 #127
20090162837
2009-06-25

Inactivated FCV vaccines

 #128
20090162396
2009-06-25

GM-negative EHV-mutants without heterologous elements

 #129
20090110697
2009-04-30

Inactivated bovine herpes virus-1 and methods

 #130
20090068223
2009-03-12

COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS

 #131
20080299149
2008-12-04

Raccoon Poxvirus Expressing Genes of Feline Antigens

 #132
20080279926
2008-11-13

Vaccine Compositions Comprising a Saponin Adjuvant

 #133
20080279888
2008-11-13

Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof

 #134
20080279886
2008-11-13

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of infection

 #135
20080199491
2008-08-21

Sustained release vaccine composition

 #136
20080171688
2008-07-17

Recombinant Vaccine from gE, gI, and gB Proteins of the Varicella-Zoster Virus for the Treatment and Prevention of Multiple Sclerosis

 #137
20080171079
2008-07-17

Vaccine

 #138
20080160046
2008-07-03

gM-negative EHV-mutants

 #139
20080050395
2008-02-28

METHODS FOR PREPARING AND DELIVERING ADJUVANT COMPOSITIONS

 #140
20070231350
2007-10-04

West Nile vaccine

 #141
20070231349
2007-10-04

West nile DNA vaccine

 #142
20070219149
2007-09-20

Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity

 #143
20070196390
2007-08-23

Equine herpesvirus vaccine

 #144
20070196389
2007-08-23

VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES

 #145
20070196384
2007-08-23

Glycolipid adjuvant compositions

 #146
20070178119
2007-08-02

Methods for preventing or ameliorating West Nile encephalitis

 #147
20070172877
2007-07-26

Methods for preventing cattle reproductive diseases

 #148
20070166802
2007-07-19

Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine

 #149
20070166330
2007-07-19

gM-negative EHV-mutants without heterologous elements

 #150
20070166326
2007-07-19

West Nile vaccine

 #151
20070166325
2007-07-19

West Nile vaccine

 #152
20070166324
2007-07-19

West Nile vaccine

 #153
20070154943
2007-07-05

Methods for preventing cattle reproductive diseases

 #154
20070031454
2007-02-08

Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus

 #155
20060222660
2006-10-05

Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference

 #156
20060160101
2006-07-20

Inactivated FCV vaccines

 #157
20060121052
2006-06-08

Recombinant vaccine from gE, gI, and gB proteins of the varicella-zoster virus for the treatment and prevention of multiple sclerosis

 #158
20060121048
2006-06-08

Genetically engineered cell lines and systems for propagating virus and methods of use thereof

 #159
20050238660
2005-10-27

Cpg formulations and related methods

 #160
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #161
20050130127
2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

 #162
20050084502
2005-04-21

Equine herpesvirus vaccine

 #163
15821774
2018-11-06

Nucleic acid-based adjuvant and porcine vaccine composition including the same

 #164
15767587
2023-05-09

Nucleic acid vaccines for varicella zoster virus (VZV)